---
title: "Endovascular thrombectomy versus medical management for mild vertebrobasilar occlusion: hierarchic"
id: "medrxiv-19-endovascular-thrombectomy-for-mild-vertebrobasilar-artery-occlusion-a"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-19-endovascular-thrombectomy-for-mild-vertebrobasilar-artery-occlusion-a"
content_type: "clinical_feed_article"
specialty: "Neurology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.09.18.26363452v1?rss=1"
published_at: "2026-09-22T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Endovascular thrombectomy versus medical management for mild vertebrobasilar occlusion: hierarchic
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-19-endovascular-thrombectomy-for-mild-vertebrobasilar-artery-occlusion-a
- **Specialty:** [Neurology](https://medichelpline.com/clinical-feed/neurology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.09.18.26363452v1?rss=1)
- **Published At:** 2026-09-22T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- This secondary analysis used a multicenter retrospective registry of acute **vertebrobasilar artery occlusion (VBAO)** with admission NIHSS ≤10 to compare **endovascular thrombectomy (EVT)** plus best medical management (BMM) versus BMM alone using a hierarchical win-ratio (WR) approach. - The cohort included 1,232 patients: 428 treated with EVT and 804 treated with BMM alone. Admission NIHSS strata of 0–5 and 6–10 were analyzed separately in exploratory analyses. - Primary hierarchical endpoints ranked death through common follow-up first, then 90-day modified Rankin Scale (mRS), and then symptomatic intracranial hemorrhage (sICH); all EVT–BMM patient pairs were compared and classified as EVT win, BMM win, or tie. - In the unadjusted overall analysis EVT had 146,674 wins, BMM had 149,958 wins, and there were 47,480 ties, producing a WR of 0.98 (95% CI 0.84–1.15; P = 0.749), indicating no net advantage for EVT. - After stabilized inverse probability of treatment weighting (IPTW), the overall WR was 0.96 (95% CI 0.80–1.14; P = 0.618); sensitivity analyses truncating weights at the 1st and 99th percentiles did not show a robust association favoring EVT. - Exploratory stratified results differed by baseline severity: for NIHSS 0–5 the WR was 0.80 (95% CI 0.61–1.05; P = 0.101), while for NIHSS 6–10 the WR favored EVT at 1.36 (95% CI 1.10–1.68; P = 0.004), suggesting a possible benefit in the higher-but-still-mild subgroup. - Authors conclude EVT showed no overall net advantage over BMM in this hierarchical analysis. The positive signal for NIHSS 6–10 is exploratory and requires confirmation in randomized trials; EVT for NIHSS 0–5 should remain cautious and individualized. - The study design and analytic approach (hierarchical win-ratio and stabilized IPTW) were intended to assess net clinical benefit across prioritized outcomes rather than a single endpoint.
## Clinical Analysis & Structured Key Points
Background Endovascular thrombectomy (EVT) is used selectively for vertebrobasilar artery occlusion (VBAO), but its net value in mild deficits remains uncertain. We performed a hierarchical win-ratio analysis of EVT versus best medical management (BMM) in patients with acute VBAO and admission National Institutes of Health Stroke Scale (NIHSS) scores of 10 or less. Methods We performed a secondary analysis of a multicenter retrospective registry of acute VBAO with admission NIHSS scores of 10 or less. EVT plus BMM was compared with BMM alone in the overall cohort and in admission NIHSS strata of 0-5 and 6-10. The primary hierarchy ranked death status through common follow-up, 90-day modified Rankin Scale score, and symptomatic intracranial hemorrhage (sICH). All EVT-BMM pairs were compared sequentially and classified as an EVT win, BMM win, or tie. The adjusted analysis used stabilized inverse probability of treatment weighting (IPTW), with weights truncated at the 1st and 99th percentiles in a sensitivity analysis. Results The analysis included 1,232 patients: 428 underwent EVT and 804 received BMM. In the unweighted overall analysis, EVT had 146,674 wins, BMM had 149,958 wins, and 47,480 ties, yielding a WR of 0.98 (95% CI, 0.84-1.15; P = 0.749). After stabilized IPTW, the WR was 0.96 (95% CI, 0.80-1.14; P = 0.618). Sensitivity analyses did not show a robust overall association favoring EVT. In exploratory NIHSS-stratified analyses, the WR was 0.80 (95% CI, 0.61-1.05; P = 0.101) for NIHSS scores of 0-5 and 1.36 (95% CI, 1.10-1.68; P = 0.004) for scores of 6-10. Conclusions EVT was not associated with an overall net advantage over BMM in this hierarchical analysis. The exploratory signal among patients with admission NIHSS scores of 6-10 suggests that EVT may be feasible in selected patients and warrants confirmation in randomized trials; for patients with NIHSS scores of 0-5, EVT use should remain cautious and individualized.
## Related Clinical Research

- [CBT-I for Insomnia Linked to Slower Biological Aging in Older Adults](https://medichelpline.com/clinical-feed/medical-news-today-0-could-treating-insomnia-slow-biological-aging-study-finds-promising-link.md)
- [Passive Advancement of the Aspiration Catheter During Thrombectomy Linked to Improved Recanalizati](https://medichelpline.com/clinical-feed/medrxiv-6-passive-advancement-of-the-aspiration-catheter-during-mechanical-thrombectomy.md)
- [Baseline ASPECTS Modifies Tenecteplase Benefit Before Thrombectomy in Large‑Vessel Occlusion Stroke](https://medichelpline.com/clinical-feed/pubmed-42623571.md) (DOI: 10.1212/WNL.0000000000218467)
- [Framework to Integrate Chronic Deep Brain Stimulation Sensing with Wearable Behavioral Monitoring](https://medichelpline.com/clinical-feed/medrxiv-3-a-reproducible-framework-for-integrating-chronic-deep-brain-stimulation-sensing.md)
- [Periodised Power Training (POWER) Pilot RCT Protocol for Chronic Stroke Recovery](https://medichelpline.com/clinical-feed/bmj-open-9-periodised-power-training-in-community-dwelling-adults-with-chronic-stroke-a.md)

## Navigation
- [← Back to Neurology Feed](https://medichelpline.com/clinical-feed/neurology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.